The U.S. Department of Health and Human Services plans to create two new deputy commissioner roles at the FDA, focusing on technology—including AI—and drugs. These roles aim to strengthen leadership amid recent FDA challenges like foodborne outbreaks and controversial drug approvals. The technology deputy commissioner will oversee AI use internally and in medical product reviews. These appointments, pending Senate confirmation of FDA commissioner Heidi Overton, reflect efforts to enhance agency oversight and adapt to emerging health tech trends.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
Atlanticus Holdings Corporation announced that its CEO Jeff Howard and CFO Bill McCamey will participate in the KBW Fintech Ecosystem Conference in New York from November 10-12, 2026. Jeff Howard will join a fireside chat titled “Beyond the Credit Sc...
United Fire Group reported a 10% decline in Q3 2026 net income to $35.1 million, or $1.34 per diluted share, despite a 13% increase in net written premiums driven by commercial business growth. The combined ratio rose to 94.6% from 91.9% due to highe...
Curaleaf Holdings reported third quarter 2026 net revenue of $353 million, up 11% year-over-year, driven by 8% domestic and 28% international growth. The company achieved an adjusted gross profit margin of 49% and adjusted EBITDA of $78 million, refl...
